Matches in Wikidata for { <http://www.wikidata.org/entity/Q59216831> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q59216831 description "article scientifique publié en 2008" @default.
- Q59216831 description "article" @default.
- Q59216831 description "wetenschappelijk artikel" @default.
- Q59216831 description "наукова стаття, опублікована у 2008" @default.
- Q59216831 name "The TOKEN study: safety and efficacy of Truvada or Kivexa in combination with efavirenz in treatment-naïve predominantly black African HIV patients" @default.
- Q59216831 name "The TOKEN study: safety and efficacy of Truvada or Kivexa in combination with efavirenz in treatment-naïve predominantly black African HIV patients" @default.
- Q59216831 type Item @default.
- Q59216831 label "The TOKEN study: safety and efficacy of Truvada or Kivexa in combination with efavirenz in treatment-naïve predominantly black African HIV patients" @default.
- Q59216831 label "The TOKEN study: safety and efficacy of Truvada or Kivexa in combination with efavirenz in treatment-naïve predominantly black African HIV patients" @default.
- Q59216831 prefLabel "The TOKEN study: safety and efficacy of Truvada or Kivexa in combination with efavirenz in treatment-naïve predominantly black African HIV patients" @default.
- Q59216831 prefLabel "The TOKEN study: safety and efficacy of Truvada or Kivexa in combination with efavirenz in treatment-naïve predominantly black African HIV patients" @default.
- Q59216831 P1433 Q59216831-EF733FE2-8CE8-4E4B-97F7-738A0E29C91A @default.
- Q59216831 P1476 Q59216831-27669C40-6EDC-4E1B-BE74-0FC03D48261C @default.
- Q59216831 P2093 Q59216831-127174B3-81C4-4790-A4D4-10EB0C8A7EA3 @default.
- Q59216831 P2093 Q59216831-7AA48D1E-7E77-452C-94B6-FF2BC405565E @default.
- Q59216831 P2093 Q59216831-8FD894B6-4525-49B4-A412-48FACDB23D8F @default.
- Q59216831 P2093 Q59216831-C0580DB7-22E1-4E19-9F04-76574A59773E @default.
- Q59216831 P2093 Q59216831-C5E2007B-F827-4E66-83E5-E2D4493E24FC @default.
- Q59216831 P2093 Q59216831-D02D2467-4DF0-44AE-8C10-016DFD026F7C @default.
- Q59216831 P2888 Q59216831-FC93FF4B-A150-4370-8805-F8B1C029BD3A @default.
- Q59216831 P304 Q59216831-D9237B2A-E2DC-444A-A429-E94CFEB4654B @default.
- Q59216831 P31 Q59216831-167BC9F7-4F12-4CD8-BE3A-392D4C8905FA @default.
- Q59216831 P356 Q59216831-24307B55-3A7E-4338-B768-171EEFC25B42 @default.
- Q59216831 P433 Q59216831-C0CC7439-6A04-41E9-825E-07C0D436F419 @default.
- Q59216831 P478 Q59216831-E09DF338-DD27-4633-9715-3DAC7ED8C816 @default.
- Q59216831 P577 Q59216831-C7807711-331A-4A6E-9B87-DBF5D74A05A6 @default.
- Q59216831 P6179 Q59216831-C6C46819-AADC-4541-BD19-A5B169371F2D @default.
- Q59216831 P921 Q59216831-21D23949-8633-4668-A942-3C4CBB75D852 @default.
- Q59216831 P921 Q59216831-696A7B36-D7C3-48DB-B960-56020005672D @default.
- Q59216831 P921 Q59216831-D7870B1E-7B4E-4452-BF4F-56F51A69B8C4 @default.
- Q59216831 P356 1758-2652-11-S1-P15 @default.
- Q59216831 P1433 Q6296158 @default.
- Q59216831 P1476 "The TOKEN study: safety and efficacy of Truvada or Kivexa in combination with efavirenz in treatment-naïve predominantly black African HIV patients" @default.
- Q59216831 P2093 "B Kumari" @default.
- Q59216831 P2093 "J Arumainayagam" @default.
- Q59216831 P2093 "L Riddell" @default.
- Q59216831 P2093 "M Ghanem" @default.
- Q59216831 P2093 "S Chandramani" @default.
- Q59216831 P2093 "S Das" @default.
- Q59216831 P2888 1758-2652-11-s1-p15 @default.
- Q59216831 P304 "P15" @default.
- Q59216831 P31 Q13442814 @default.
- Q59216831 P356 "10.1186/1758-2652-11-S1-P15" @default.
- Q59216831 P433 "Suppl 1" @default.
- Q59216831 P478 "11" @default.
- Q59216831 P577 "2008-01-01T00:00:00Z" @default.
- Q59216831 P6179 "1052961144" @default.
- Q59216831 P921 Q18123741 @default.
- Q59216831 P921 Q2412859 @default.
- Q59216831 P921 Q422645 @default.